Impact of late effects on health-related quality of life in survivors of pediatric brain tumors

Cancer Nursing

Volumn 37, Issue 6, 2014, Pages E1-E14

  Sato, Iori ^a   Higuchi, Akiko ^a,b   Yanagisawa, Takaaki ^c   Murayama, Shiho ^a   Kumabe, Toshihiro ^d   Sugiyama, Kazuhiko ^e   Mukasa, Akitake ^f   Saito, Nobuhito ^f   Sawamura, Yutaka ^g   Terasaki, Mizuhiko ^h   Shibui, Soichiro ⁱ   Takahashi, Jun ^j   Nishikawa, Ryo ^c   Ishida, Yasushi ^k   Kamibeppu, Kiyoko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Children's Cancer Association of Japan   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g Sawamura Neurosurgery Clinic   (Japan)

^h KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NATIONAL CANCER CENTER HOSPITAL   (Japan)

^j Kitano Hospital   (Japan)

^k EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

more..

Author keywords

Adolescent; Brain neoplasms; Child; Multicenter study; Propensity score; Quality of life; Questionnaires; Survivors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; BRAIN DYSFUNCTION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; DROWSINESS; EMOTION; FATIGUE; FEMALE; GERM CELL TUMOR; GLIOMA; HUMAN; INSOMNIA; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MOBILIZATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEIZURE; SOCIAL INTERACTION; VISUAL IMPAIRMENT; ATAXIA; BRAIN DISEASE; COMPLICATION; ENDOCRINE DISEASE; JAPAN; MOTOR DYSFUNCTION; PEDIATRICS; PSYCHOLOGY; VISUAL DISORDER;

ADOLESCENT; ATAXIA; BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; JAPAN; MALE; MOTOR DISORDERS; PEDIATRICS; QUALITY OF LIFE; SEIZURES; SURVEYS AND QUESTIONNAIRES; VISION DISORDERS;

EID: 84927796281     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0000000000000110     Document Type: Article

References (49)

1. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006; 24(25): 4202-4208.
2. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma- 96): Long-term results from a prospective, multicentre trial. Lancet Oncol. 2006; 7(10): 813-820.
3. Jemal A, Siegel R,Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin. 2009; 59(4): 225-249.
4. The Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1984-2000) 12th edition. Neurol Med Chir. 2009; 49(suppl): 35-37.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer.N Engl JMed. 2006; 355(15): 1572-1582.
6. ArmstrongGT, LiuQ, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27(14): 2328-2338.
7. Zebrack BJ, Gurney JG,Oeffinger K, et al. Psychological outcomes in longterm survivors of childhood brain cancer: A report fromthe Childhood Cancer Survivor Study. J Clin Oncol. 2004; 22(6): 999-1006.
8. Zeltzer LK, Recklitis C, Buchbinder D, et al. Psychological status in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27(14): 2396-2404.
9. Gurney JG, KrullKR, Kadan-Lottick N, et al. Social outcomes in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; 27(14): 2390-2395.
10. TestaMA, Simonson DC. Assessment of quality-of-life outcomes. New Engl J Med. 1996; 334(13): 835-840.
11. Kennedy C, Glaser A. Quality of survival. In: Walker DA, Perilongo G, Taylor RE, Punt JA, eds. Brain and Spinal Tumors of Childhood. London, England: Edward Arnold; 2004: 493-514.
12. Bhat SR,Goodwin TL, Burwinkle TM, et al. Profile of daily life in children with brain tumors: An assessment of health-related quality of life. J Clin Oncol. 2005; 23(24): 5493-5500.
13. Meeske KA, Patel SK, Palmer SN, et al. Factors associated with healthrelated quality of life in pediatric cancer survivors. Pediatr Blood Cancer. 2007; 49(3): 298-305.
14. Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and healthrelated quality of life in adult childhood cancer survivors: A report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2008; 17(2): 435-446.
15. Aarsen FK, Paquier PF, Reddingius RE, et al. Functional outcome after lowgrade astrocytoma treatment in childhood. Cancer. 2006; 106(2): 396-402.
16. Aarsen FK, Paquier PF, ArtsW-FM, et al. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol. 2009; 27(21): 3526-3532.
17. Benesch M, Spiegl K, Winter A, et al. A scoring system to quantify late effects in children after treatment for medulloblastoma/ependymoma and its correlation with quality of life and neurocognitive functioning. Childs Nerv Syst. 2009; 25(2): 173-181.
18. Gerber NU, Zehnder D, Zuzak TJ, et al. Outcome in children with brain tumours diagnosed in the first year of life: Long-term complications and quality of life. Arch Disease Child. 2008; 93(7): 582-589.
19. Lannering B,Marky I, Lundberg A, et al. Long-term sequelae after pediatric brain tumors: Their effect on disability and quality of life. Med Pediatr Oncol. 1990; 18(4): 304-310.
20. Reimers TS, Mortensen EL, Nysom K, et al. Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer. 2009; 53(6): 1086-1091.
21. Sutton LN, Radcliffe J, Goldwein JW, et al. Quality of life of adult survivors of germinomas treated with craniospinal irradiation. Neurosurgery. 1999; 45(6): 1292-1297.
22. Stam H, Hartman EE, Deurloo JA, et al. Young adult patients with a history of pediatric disease: Impact on course of life and transition into adulthood. J Adolesc Health. 2006; 39(1): 4-13.
23. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol. 2003; 21(17): 3255-3261.
24. Gurney JG, Kadan-Lottick NS, Packer RJ Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer. 2003; 97(3): 663-673.
25. Pietila S, Korpela R, Lenko HL, et al. Neurological outcome of childhood brain tumor survivors. J Neurooncol. 2012; 108(1): 153-161.
26. Matsutani M, Japanese Pediatric Brain Tumor Study Group. Combined chemotherapy and radiation therapy for CNS germ cell tumorsVthe Japanese experience. J Neurooncol. 2001; 54(3): 311-316.
27. Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol. 2009; 10(3): 258-266.
28. Osoba D, Aaronson NK,MullerM, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996; 5(1): 139-150.
29. Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer. 1998; 34(6): 810-815.
30. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of CancerQLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5): 365-376.
31. Kobayashi K, Kamibeppu K. Measuring quality of life in Japanese children: Development of the Japanese version of PedsQL. Pediatr Int. 2010; 52(1): 80-88.
32. Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL in pediatric cancer: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002; 94(7): 2090-2106.
33. Sato I, Higuchi A, Yanagisawa T, et al. Development of the Japanese version of the Pediatric Quality of Life Inventory Brain Tumor Module. Health Qual Life Outcomes. 2010; 8(1): 38.
34. Palmer SN,Meeske KA, Katz ER, et al. The PedsQL Brain Tumor Module: Initial reliability and validity. Pediatr Blood Cancer. 2007; 49(3): 287-293.
35. Tsuji N, Kakee N, Ishida Y, et al. Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Health Qual Life Outcomes. 2011; 9(1): 22.
36. Rosenbaum PR, Rubin DR. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983; 70(1): 41-55.
37. Rubin DR. The use of propensity scores in applied Bayesian inference. In: Bernardo JM, de Groot MH, Lindley DV, Smith AFM, eds. Bayesian Statistics. Vol. 2. North-Holland: Elsevier Science Publisher BV; 1985: 463-472.
38. Maringwa J, Quinten C, King M, et al. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol. 2011; 22(9): 2107-2112.
39. Maringwa JT,QuintenC, King M, et al. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQC30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer. 2011; 19(11): 1753-1760.
40. Taphoorn MJB, Claassens L, Aaronson NK, et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010; 46(6): 1033-1040.
41. Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr. 2003; 3(6): 329-341.
42. Blaauwbroek R, Stant AD, Groenier KH, et al. Health-related quality of life and adverse late effects in adult (very) long-term childhood cancer survivors. Eur J Cancer. 2007; 43(1): 122-130.
43. Bazil CW. Effects of antiepileptic drugs on sleep structure: Are all drugs equal? CNS Drugs. 2003; 17(10): 719-728.
44. Owsley C, McGwin G. Measuring the personal burden of eye disease and vision impairment. Ophthal Epidemiol. 2007; 14(4): 188-191.
45. Dekker R, Koole FD. Visually impaired children's visual characteristics and intelligence. Dev Med Child Neurol. 1992; 34(2): 123-133.
46. Suzuki K. Cognitive dysfunction in patients with brain tumor. Nippon Rinsho. 2010; 68(Suppl 10): 653-656.
47. Mulhern RK, Palmer SL,Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy for childhoodmedulloblastoma.J Clin Oncol. 2005; 23: 5511-5519.
48. Anderson NE. Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol. 2003; 16(6): 677-683.
49. Ullrich NJ, Embry L. Neurocognitive dysfunction in survivors of childhood brain tumors. Semin Pediatr Neurol. 2012; 19(1): 35-42.